KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer
Abstract Lysine (K)-specific demethylase 6B (KDM6B), a stress-inducible H3K27me3 demethylase, plays oncogenic or antitumoral roles in malignant tumors depending on the type of tumor cell. However, how this histone modifier affects the progression of prostate cancer (PCa) is still unknown. Here we an...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-020-03354-4 |
id |
doaj-d638d6981b494bdf804b0c1b96a7bb4f |
---|---|
record_format |
Article |
spelling |
doaj-d638d6981b494bdf804b0c1b96a7bb4f2021-01-10T12:07:36ZengNature Publishing GroupCell Death and Disease2041-48892021-01-0112111510.1038/s41419-020-03354-4KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancerZhi Cao0Xiaolei Shi1Feng Tian2Yu Fang3Jason Boyang Wu4Stefan Mrdenovic5Xinwen Nian6Jin Ji7Huan Xu8Chen Kong9Yalong Xu10Xi Chen11Yuhua Huang12Xuedong Wei13Yongwei Yu14Bo Yang15Leland W. K. Chung16Fubo Wang17Department of Urology, Changhai Hospital, Navy Medical UniversityDepartment of Urology, Changhai Hospital, Navy Medical UniversityDepartment of Urology, The Eighth People’s Hospital of ShanghaiDepartment of Urology, Changhai Hospital, Navy Medical UniversityDepartment of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State UniversityUro-Oncology Research Program, Samuel Oschin Comprehensive Cancer Institute, Department of Medicine, Cedars-Sinai Medical CenterDepartment of Urology, Changhai Hospital, Navy Medical UniversityDepartment of Urology, Changhai Hospital, Navy Medical UniversityDepartment of Urology, Changhai Hospital, Navy Medical UniversityDepartment of Traditional Chinese Medicine, New Jiangwan City Community Health Service CentreDepartment of Urology, Changhai Hospital, Navy Medical UniversityDepartment of Urology, Changhai Hospital, Navy Medical UniversityDepartment of Urology, The First Affiliated Hospital of Soochow UniversityDepartment of Urology, The First Affiliated Hospital of Soochow UniversityDepartment of Pathology, Changhai Hospital, Navy Medical UniversityDepartment of Urology, Changhai Hospital, Navy Medical UniversityUro-Oncology Research Program, Samuel Oschin Comprehensive Cancer Institute, Department of Medicine, Cedars-Sinai Medical CenterDepartment of Urology, Changhai Hospital, Navy Medical UniversityAbstract Lysine (K)-specific demethylase 6B (KDM6B), a stress-inducible H3K27me3 demethylase, plays oncogenic or antitumoral roles in malignant tumors depending on the type of tumor cell. However, how this histone modifier affects the progression of prostate cancer (PCa) is still unknown. Here we analyzed sequenced gene expression data and tissue microarray to explore the expression features and prognostic value of KDM6B in PCa. Further, we performed in vitro cell biological experiments and in vivo nude mouse models to reveal the biological function, upstream and downstream regulation mechanism of KDM6B. In addition, we investigated the effects of a KDM6B inhibitor, GSK-J4, on PCa cells. We showed that KDM6B overexpression was observed in PCa, and elevated KDM6B expression was associated with high Gleason Score, low serum prostate-specific antigen level and shorted recurrence-free survival. Moreover, KDM6B prompted proliferation, migration, invasion and cell cycle progression and suppressed apoptosis in PCa cells. GSK-J4 administration could significantly suppress the biological function of KDM6B in PCa cells. KDM6B is involved in the development of castration-resistant prostate cancer (CRPC), and combination of MDV3100 plus GSK-J4 is effective for CRPC and MDV3100-resistant CRPC. Mechanism exploration revealed that androgen receptor can decrease the transcription of KDM6B and that KDM6B demethylates H3K27me3 at the cyclin D1 promoter and cooperates with smad2/3 to prompt the expression of cyclin D1. In conclusion, our study demonstrates that KDM6B is an androgen receptor regulated gene and plays oncogenic roles by promoting cyclin D1 transcription in PCa and GSK-J4 has the potential to be a promising agent for the treatment of PCa.https://doi.org/10.1038/s41419-020-03354-4 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhi Cao Xiaolei Shi Feng Tian Yu Fang Jason Boyang Wu Stefan Mrdenovic Xinwen Nian Jin Ji Huan Xu Chen Kong Yalong Xu Xi Chen Yuhua Huang Xuedong Wei Yongwei Yu Bo Yang Leland W. K. Chung Fubo Wang |
spellingShingle |
Zhi Cao Xiaolei Shi Feng Tian Yu Fang Jason Boyang Wu Stefan Mrdenovic Xinwen Nian Jin Ji Huan Xu Chen Kong Yalong Xu Xi Chen Yuhua Huang Xuedong Wei Yongwei Yu Bo Yang Leland W. K. Chung Fubo Wang KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer Cell Death and Disease |
author_facet |
Zhi Cao Xiaolei Shi Feng Tian Yu Fang Jason Boyang Wu Stefan Mrdenovic Xinwen Nian Jin Ji Huan Xu Chen Kong Yalong Xu Xi Chen Yuhua Huang Xuedong Wei Yongwei Yu Bo Yang Leland W. K. Chung Fubo Wang |
author_sort |
Zhi Cao |
title |
KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer |
title_short |
KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer |
title_full |
KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer |
title_fullStr |
KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer |
title_full_unstemmed |
KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer |
title_sort |
kdm6b is an androgen regulated gene and plays oncogenic roles by demethylating h3k27me3 at cyclin d1 promoter in prostate cancer |
publisher |
Nature Publishing Group |
series |
Cell Death and Disease |
issn |
2041-4889 |
publishDate |
2021-01-01 |
description |
Abstract Lysine (K)-specific demethylase 6B (KDM6B), a stress-inducible H3K27me3 demethylase, plays oncogenic or antitumoral roles in malignant tumors depending on the type of tumor cell. However, how this histone modifier affects the progression of prostate cancer (PCa) is still unknown. Here we analyzed sequenced gene expression data and tissue microarray to explore the expression features and prognostic value of KDM6B in PCa. Further, we performed in vitro cell biological experiments and in vivo nude mouse models to reveal the biological function, upstream and downstream regulation mechanism of KDM6B. In addition, we investigated the effects of a KDM6B inhibitor, GSK-J4, on PCa cells. We showed that KDM6B overexpression was observed in PCa, and elevated KDM6B expression was associated with high Gleason Score, low serum prostate-specific antigen level and shorted recurrence-free survival. Moreover, KDM6B prompted proliferation, migration, invasion and cell cycle progression and suppressed apoptosis in PCa cells. GSK-J4 administration could significantly suppress the biological function of KDM6B in PCa cells. KDM6B is involved in the development of castration-resistant prostate cancer (CRPC), and combination of MDV3100 plus GSK-J4 is effective for CRPC and MDV3100-resistant CRPC. Mechanism exploration revealed that androgen receptor can decrease the transcription of KDM6B and that KDM6B demethylates H3K27me3 at the cyclin D1 promoter and cooperates with smad2/3 to prompt the expression of cyclin D1. In conclusion, our study demonstrates that KDM6B is an androgen receptor regulated gene and plays oncogenic roles by promoting cyclin D1 transcription in PCa and GSK-J4 has the potential to be a promising agent for the treatment of PCa. |
url |
https://doi.org/10.1038/s41419-020-03354-4 |
work_keys_str_mv |
AT zhicao kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT xiaoleishi kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT fengtian kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT yufang kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT jasonboyangwu kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT stefanmrdenovic kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT xinwennian kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT jinji kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT huanxu kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT chenkong kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT yalongxu kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT xichen kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT yuhuahuang kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT xuedongwei kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT yongweiyu kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT boyang kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT lelandwkchung kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer AT fubowang kdm6bisanandrogenregulatedgeneandplaysoncogenicrolesbydemethylatingh3k27me3atcyclind1promoterinprostatecancer |
_version_ |
1724343433589424128 |